<VariationArchive VariationID="3068880" VariationName="NC_000001.10:g.(?_21835915)_(21904904_?)del" VariationType="Deletion" Accession="VCV003068880" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-04-20" DateCreated="2024-04-15" MostRecentSubmission="2024-04-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3228205" VariationID="3068880">
      <GeneList>
        <Gene Symbol="ALPL" FullName="alkaline phosphatase, biomineralization associated" GeneID="249" HGNC_ID="HGNC:438" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p36.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="21508984" stop="21578410" display_start="21508984" display_stop="21578410" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="21835857" stop="21904904" display_start="21835857" display_stop="21904904" Strand="+" />
          </Location>
          <OMIM>171760</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000001.10:g.(?_21835915)_(21904904_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p36.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" innerStart="21835915" innerStop="21904904" display_start="21835915" display_stop="21904904" variantLength="68990" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.(?_21835915)_(21904904_?)del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.(?_21835915)_(21904904_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000001.10:g.(?_21835915)_(21904904_?)del AND Hypophosphatasia" Accession="RCV003994940" Version="1">
        <ClassifiedConditionList TraitSetID="8894">
          <ClassifiedCondition DB="MedGen" ID="C0020630">Hypophosphatasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-02-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-20" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-04-15" MostRecentSubmission="2024-04-15">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="8894" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="14484" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hypophosphatasia</ElementValue>
                <XRef ID="23875" DB="GeneTests" />
                <XRef ID="Hypophosphatasia/3677" DB="Genetic Alliance" />
                <XRef ID="MONDO:0018570" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Phosphoethanol-aminuria</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Hypophosphatasia is characterized by defective mineralization of growing or remodeling bone, with or without root-intact tooth loss, in the presence of low activity of serum and bone alkaline phosphatase. Clinical features range from stillbirth without mineralized bone at the severe end to pathologic fractures of the lower extremities in later adulthood at the mild end. While the disease spectrum is a continuum, seven clinical forms of hypophosphatasia are usually recognized based on age at diagnosis and severity of features: Perinatal (severe): characterized by pulmonary insufficiency and hypercalcemia. Perinatal (benign): prenatal skeletal manifestations that slowly resolve into one of the milder forms. Infantile: onset between birth and age six months of clinical features of rickets without elevated serum alkaline phosphatase activity. Severe childhood (juvenile): variable presenting features progressing to rickets. Mild childhood: low bone mineral density for age, increased risk of fracture, and premature loss of primary teeth with intact roots. Adult: characterized by stress fractures and pseudofractures of the lower extremities in middle age, sometimes associated with early loss of adult dentition. Odontohypophosphatasia: characterized by premature exfoliation of primary teeth and/or severe dental caries without skeletal manifestations.</Attribute>
                <XRef ID="NBK1150" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6734" />
                <XRef ID="6734" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301329</ID>
                <ID Source="BookShelf">NBK1150</ID>
              </Citation>
              <XRef ID="436" DB="Orphanet" />
              <XRef ID="C0020630" DB="MedGen" />
              <XRef ID="MONDO:0018570" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8998202" SubmissionDate="2024-04-03" DateLastUpdated="2024-04-15" DateCreated="2024-04-15">
        <ClinVarSubmissionID localKey="NC_000001.10:g.(?_21835915)_(21904904_?)del|MedGen:C0020630" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004813607" DateUpdated="2024-04-15" DateCreated="2024-04-15" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Variant summary: The variant involves the deletion of exons 1-12 in the ALPL gene. This deletion includes the entire coding sequence of the gene. As the exact proximal and distal breakpoints are unknown, it may extend beyond the annotated region of the gene to include other flanking genes. A presumed nomenclature of c.(?_-200)_(*763_?)del has been designated for the purposes of this classification. The variant was absent in 21692 control chromosomes (gnomAD). To our knowledge, no occurrence of c.(?_-200)_(*763_?)del in individuals affected with Hypophosphatasia and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 1074110). Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALPL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.(?_21835915)_(21904904_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0020630" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14342304</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8998202" TraitType="Disease" MappingType="XRef" MappingValue="C0020630" MappingRef="MedGen">
        <MedGen CUI="C0020630" Name="Hypophosphatasia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>